Brent DuBeshter, M.D.

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 668
Rochester, New York 14642

Office: 585 442-8020

Fax: 585 442-8039

Portrait

Current Appointments

Education
MD Medicine Univ of Virginia Sch Medicine 1978
BA Chemistry Franklin & Marshall Coll 1974
Post-Doctoral Training & Residency
Fellow in Gynecologic Oncology Brigham and Women's Hospital Boston, MA 02115 1984 - 1986
Resident in Obstetrics & Gynecology Brigham and Women's Hospital Boston, MA 02115 1978 - 1982
Internship, Brigham & Women's Hospital, Boston, Ma. 1978 - 1979
Board Certifications
American Board of Obstetrics and Gynecology, Recertification 1996
American Board of Obstetrics and Gynecology (Gynecologic Oncology) 1988
American Board of Obstetrics and Gynecology 1987
National Board of Medical Examiners 1979
American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology, Re-certification
Recent Journal Articles
Showing the 5 most recent journal articles. (42 available)
Reynolds EA; DuBeshter B; Katzman P; Larson K; Katzel S; Glantz C. "Expression of CD44, E-cadherin, and antimetastatic protein nm23-H1 in complete hydatidiform moles." Gynecologic oncology. 2007; 104(2):451-4. Epub 2006 Oct 04.
DuBeshter, B; Griggs, J; Angel, C; Loughner, J. "Chemotherapy dose limits set by users of a computer order entry system". Hospital Pharmacy 41 (2006): 136-142.
DuBeshter, B; Walsh, CJ; Altobelli, K; Loughner, J; Angel, C. "Experience with computerized chemotherapy order entry". Journal of Oncology Practice 2 (2006): 49-52.
Brown AK; Gillis S; Deuel C; Angel C; Glantz C; Dubeshter B. "Abnormal cervical cytology: a risk factor for endometrial cancer recurrence." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2005; 15(3):517-22.
DuBeshter B; Estler K; Altobelli K; McDonald S; Glantz C; Angel C. "High-dose rate brachytherapy for Stage I/II papillary serous or clear cell endometrial cancer." Gynecologic oncology. 2004; 94(2):383-6.